Various Pharmacogenetic Aspects of Antiepileptic Drug Therapy
Authors:
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 21 (2) , 143-164
Abstract
Pharmacogenetics concerns the influence of an individual’s genetic background on the pharmacokinetics and pharmacodynamics of xenobiotics. Much of the pharmacogenetic data in the field of epilepsy...Keywords
This publication has 155 references indexed in Scilit:
- Implications of genetic polymorphisms in drug transporters for pharmacotherapyCancer Letters, 2006
- UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: I. Identification of Polymorphisms in the 5′-Regulatory and Exon 1 Regions, and Association with Human Liver UGT1A6 Gene Expression and GlucuronidationThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Genotype???phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and womenPharmacogenetics, 2003
- Genetics of temporal lobe epilepsyJournal of Neurology, Neurosurgery & Psychiatry, 2003
- The genetics of human epilepsyTrends in Pharmacological Sciences, 2003
- A Single Nucleotide Polymorphism of CYP2B6 Found in Japanese Enhances Catalytic Activity by AutoactivationBiochemical and Biophysical Research Communications, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- VPA-induced neural tube defects in mice. I. altered metabolism of sulfur amino acids and glutathioneTeratogenesis, Carcinogenesis, and Mutagenesis, 1998
- SOME STATISTICAL DATA ON ATYPICAL CHOLINESTERASE OF HUMAN SERUMAnnals of Human Genetics, 1959
- THE FAMILIAL INCIDENCE OF LOW PSEUDOCHOLINESTERASE LEVELThe Lancet, 1956